Moomoo report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Why ULBI Stock Traded Steady Today — RQD Quant Desk Flash
Ultralife Corporation (ULBI) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Ultralife Corporation (NASDAQ: ULBI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $15.62 (0.00% 1D, market cap $260.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 7/20. Across 486 tracked Industrials issuers, ULBI ranks #167 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ULBI compare to ELVA and CHPT in the Industrials sector?
▼
Within the Industrials sector (Industrial Machinery/Components), ULBI carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of 24.1%, and ROIC of -2.8%. By comparison, ELVA (Electrovaya Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC —, cap $264.0M) and CHPT (ChargePoint Holdings Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $256.2M). Among the 5-stock peer group, ULBI leads on earnings multiple (N/A) while ALTG leads on capital efficiency (4.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ULBI?
▼
Per ULBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000875657), Ultralife Corporation generated $191.2M in revenue (+16.2% YoY), -$5.9M in net income, and $7.1M in free cash flow against $216.9M in total assets and $45.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
20D Institutional Volume Accumulation (±7% realized swing band)
FRED Regime × Technicals: 99% of 52W Range • RSI-14 at 92 (OVERBOUGHT (>70))
Disciplined Float (+0.16% YoY Shares) & executive Form 4 sales trim 13 pts from alignment
⚔️ Adversarial Opposing Case: Why the ULBI Bull Thesis Could Fail
Even with a 56/100 (D+) score, ULBI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($7.06) or 200D SMA ($6.56) invalidates the momentum regime and cuts Target Base ($15.48) toward Bear Floor ($12.07).
Why ULBI Stock Traded Steady Today — RQD Quant Desk Flash
Ultralife Corporation (ULBI) slipped 0.00% to $15.62, trading at 99% of its 52-week range ($4.9 – $15.67). Stretched risk/reward at current multiples (-3% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 99% of its 52-week range ($4.9 – $15.67) with RSI-14 at 92 (OVERBOUGHT (>70)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7% around $15.62 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 24.1% gross margin and $7.1M annual free cash flow.
TradingView report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Kalkine report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
US unusual-volume stocks include ONEG, CENN, SLGB, INLF and others, with volume compared with 50-day averages and price moves detailed in the latest scan.
Preview next weekâs market movers: jobs data, PMI reports, major earnings from Apple and AMD, and IPO buzz. Read here for more details.
Unusual volume scan: CETX fell 20.51%, BURU dropped 25.76%, SLGB rose 50.15%, and WKHS gained 13.33%, each with volume above 50-day averages.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ULBI)
- ✓Walkthrough of ULBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
ULBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +16.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ULBI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ULBI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ULBI)
1. Head-to-Head Industrials Peer Comparison (ULBI vs. ELVA, CHPT, AZ, ALTG)
Industry: Industrial Machinery/Components (208 Tracked Issuers)Across 486 tracked Industrials securities in the Roarable RQD universe, Ultralife Corporation (ULBI) ranks #167 by composite RQD confidence (56/100, grade D+) and #335 by equity capitalization ($260.3M). Within this direct 5-issuer industry benchmark cohort, ULBI leads on earnings valuation at N/A trailing P/E, while ALTG leads on capital efficiency and profitability with 4.0% ROIC and 25.9% gross margin. ULBI currently leads its immediate peer cohort in composite quantitative strength at 56/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ULBI
ACTIVE
Ultralife Corporation | D+ | 56/100 | — | 24.1% | -2.8% | 0.00% | $260.3M | Benchmark Subject |
| ELVA Electrovaya Inc. | D | 44/100 | — | — | — | -0.19% | $264.0M | /elva-vs-ulbi → |
| CHPT ChargePoint Holdings Inc. | D- | 37/100 | — | 30.5% | -35.0% | +3.56% | $256.2M | /chpt-vs-ulbi → |
| AZ A2Z Cust2Mate Solutions Corp. | D | 51/100 | — | — | — | -0.16% | $275.0M | /az-vs-ulbi → |
| ALTG Alta Equipment Group Inc. (Class A) | D | 51/100 | — | 25.9% | 4.0% | +0.81% | $241.1M | /altg-vs-ulbi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000875657 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Ultralife Corporation (ULBI) reported GAAP revenue of $191.2M (+16.2% vs. FY2024 revenue of $164.5M , and +20.5% cumulative change since FY2023) , GAAP net income of -$5.9M, operating cash flow of $11.0M, and free cash flow of $7.1M (-51.6% YoY). On the balance sheet, ULBI closed FY2025 with $216.9M in total assets against $45.5M in total debt (Altman Z-Score: 2.71, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $191.2M | -$5.9M | $11.0M | $7.1M | $216.9M | $45.5M |
| FY2024 (FY) | 2024-12-31 | $164.5M | $6.3M | $16.6M | $14.7M | $220.5M | $51.5M |
| FY2023 (FY) | 2023-12-31 | $158.6M | $7.2M | $1.9M | $1.9M | — | — |
3. ULBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Ultralife Corporation (NASDAQ: ULBI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $15.62 (0.00% 1D, market cap $260.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 7/20. Across 486 tracked Industrials issuers, ULBI ranks #167 in composite RQD confidence.
How does ULBI compare to ELVA and CHPT in the Industrials sector?
Within the Industrials sector (Industrial Machinery/Components), ULBI carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of 24.1%, and ROIC of -2.8%. By comparison, ELVA (Electrovaya Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC —, cap $264.0M) and CHPT (ChargePoint Holdings Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $256.2M). Among the 5-stock peer group, ULBI leads on earnings multiple (N/A) while ALTG leads on capital efficiency (4.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ULBI?
Per ULBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000875657), Ultralife Corporation generated $191.2M in revenue (+16.2% YoY), -$5.9M in net income, and $7.1M in free cash flow against $216.9M in total assets and $45.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ULBI trading relative to its 50-day, 200-day, and 52-week technical levels?
ULBI last traded at $15.62 (0.00% on volume of 248,411 shares), positioning the stock +121.25% above its 50-day simple moving average ($7.06) and +138.11% above its 200-day simple moving average ($6.56). Across its 52-week range of $4.90 to $15.67, ULBI sits at the 99.5% percentile with a 14-day RSI of 93.4 (OVERBOUGHT (>70)) and an implied next-earnings move of ±7.0% ($14.53 to $16.71).
ULBI — Ultralife Corporation: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Ultralife Corporation (ULBI) earns a live Roarable RQD composite score of 56/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $15.62 (0.00% 1D, market capitalization $260.3M).
- Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of -2.8%, gross margin of 24.1%, operating margin of -3.1%, and free cash flow yield of 2.73%.
- Whale 13F & Options Flow (15/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (13/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.71, Piotroski F-Score of 6/9, and Debt/Equity of 0.35x.
2. Business Model, Unit Margins & SEC Financial Trajectory
Ultralife Corporation (ULBI) is a NASDAQ-listed issuer classified in the Industrials sector and the Industrial Machinery/Components industry. The company's market capitalization is listed at $0.3B in the profile.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Ultralife Corporation (ULBI) reported $191.2M in annual revenue (up from $164.5M in FY2024, +16.2% YoY) and -$5.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($158.6M revenue, $7.2M net income) through FY2025, ULBI scaled operating cash flow to $11.0M and free cash flow to $7.1M, backed by $216.9M in total assets against $45.5M in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D+ • RQD 56/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of 2.73% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.90 – $15.67 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -3.1% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
Operating in Industrial Machinery/Components (Industrials), ULBI carries a macro regime beta of 1.00 and gross margin of 24.1%.
- Key Question #1: Can ULBI sustain or expand its -3.1% operating margin and -2.8% ROIC against Industrial Machinery/Components peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $191.2M and free cash flow of $7.1M, how will capital allocation balance growth reinvestment against $45.5M in total debt?
- Key Question #3: How sensitive is ULBI's equity valuation to Industrials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
ULBI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Ultralife Corporation (ULBI) • Click "Debate This Headline" to argue it in the Roar Pit below
Moomoo report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
GuruFocus report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Kalkine report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.
US unusual-volume stocks include ONEG, CENN, SLGB, INLF and others, with volume compared with 50-day averages and price moves detailed in the latest scan.
ULBI Bull vs. Bear Conversation Board — What's Your Call at $15.62?
Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price c
Don't sleep on ULBI's setup in Industrials. Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price catalyst.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (56/100) backs up the fundamental quality.
@SiliconVal_Bull Agree on the RQD 56/100 quality, though with 1.0 beta I'm scaling in with half-size at $15.62 and keeping dry powder in case we test $14.53.
Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating retu
Sitting on the sidelines or leaning short ULBI above $15.62. Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating returns.. Until Fundamental Cash Engine (11/20) and FCF yield (2.73%) inflect higher, upside is capped near $15.67.